Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Australian Patent Office (APO) has granted Mannatech, a developer and provider of nutritional supplements, for technology related to its Ambrotose AO product.
Subscribe to our email newsletter
With this, Mannatech will now hold 12 patents for technology related to Ambrotose AO in Australia, Mexico, New Zealand, Singapore, South Africa and South Korea.
Mannatech co-CEO and chief science officer Robert Sinnott said Ambrotose AO technology has been granted patents consistently from governing bodies around the world; thus, validating the diligence and scientific research the company puts behind this important product for health and wellness.
Mannatech holds 63 patents in 30 countries for its health-related technologies.